Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China · Delayed Price · Currency is CNY 16.82
+0.77 (4.80%)
May 12, 2026, 3:00 PM CST
Cabio Biotech (Wuhan) Market Cap
Cabio Biotech (Wuhan) has a market cap or net worth of 2.77 billion as of May 12, 2026. Its market cap has decreased by -25.98% in one year.
Market Cap
2.77B
Enterprise Value
2.59B
Revenue
418.18M
Ranking
n/a
PE Ratio
51.03
Stock Price
16.82
Market Cap Chart
Since December 19, 2019, Cabio Biotech (Wuhan)'s market cap has decreased from 5.54B to 2.77B, a decrease of -50.06%. That is a compound annual growth rate of -10.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 2.67B | -31.24% |
| Dec 31, 2025 | 3.88B | 21.24% |
| Dec 31, 2024 | 3.20B | 6.31% |
| Dec 29, 2023 | 3.01B | -44.60% |
| Dec 30, 2022 | 5.44B | -26.24% |
| Dec 31, 2021 | 7.37B | 55.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Model Organisms Center | 3.13B |
| Landfar Bio-medicine | 3.12B |
| Shandong Sito Bio-technology | 2.95B |
| Suzhou Fushilai Pharmaceutical | 2.78B |
| Jilin Jian Yisheng Pharmaceutical | 2.77B |
| Shanghai Universal Biotech | 2.76B |
| Jiangsu CoWin Biotech | 2.40B |
| Shanghai Hile Bio-Technology | 2.39B |